| BARDA |
BARDA |
92%
|
BARDA income consisted of funding from BARDA, under the Assistant Secretary for Preparedness and Response, within the U.S. Department of Health and Human Services, under ongoing USG Contract No. HHSO… |
| COSMOTEC |
COSMOTEC |
90%
|
the commencement of commercial sales with our partner COSMOTEC in Japan |
| STEDICAL |
STEDICAL |
90%
|
Under the terms of the Distribution Agreement, the Company holds the exclusive rights to market, sell, and distribute PermeaDerm products, including any future enhancements or modifications, within t… |
| BENELUX-ASCLEPIOS-GMBH |
BENELUX-ASCLEPIOS-GMBH |
85%
|
Sales revenue related to the RPKs, and $ 189,000 in Lease revenue related to the RPD in the Consolidated Statement of Operations. Distributor Transactions For international markets, the Company exclu… |
| JAPAN-JOINT-OPERATIONS-LTD |
JAPAN-JOINT-OPERATIONS-LTD |
85%
|
Sales revenue related to the RPKs, and $ 189,000 in Lease revenue related to the RPD in the Consolidated Statement of Operations. Distributor Transactions For international markets, the Company exclu… |
| AVITA-MEDICAL-AMERICAS-LLC |
AVITA-MEDICAL-AMERICAS-LLC |
62%
|
quarter of 2027, subject to the achievement of a certain revenue milestone. This facility also establishes trailing twelve-month (“TTM”) revenue covenants aligned with our current operating trajector… |
| C3-OPERATIONS-PTY-LTD |
C3-OPERATIONS-PTY-LTD |
62%
|
supply for key components, subassemblies and materials, and the majority of critical raw materials and services have multiple qualified suppliers. While a small number of materials remain single sour… |
| INFAMED-PTY-LTD |
INFAMED-PTY-LTD |
62%
|
29 )% Gross profit 42,363 28,380 13,983 49 % BARDA income 1,428 3,215 (1,787 ) (56 )% Operating expenses: Sales and marketing (37,291 ) (21,913 ) (15,378 ) (70 )% General and administrative (28,334 )… |
| JAPAN-POLYMEDICS-INNOVATION-GMBH |
JAPAN-POLYMEDICS-INNOVATION-GMBH |
62%
|
to the RPK and $ 358,000 in Lease revenue related to the RPD in the Consolidated Statement of Operations. Distributor Transactions For international markets, the Company exclusively partners with thi… |
| JOINT-OPERATIONS-LTD |
JOINT-OPERATIONS-LTD |
62%
|
pan, Joint Operations Ltd in the United Kingdom, medicalsol in Switzerland, Revolution Surgical Pty Ltd in Australia and New Zealand, and Sorbion in Austria). Revenue recognition occurs when the dist… |
| ORBIMED-ADVISORS-LLC |
ORBIMED-ADVISORS-LLC |
62%
|
29 )% Gross profit 42,363 28,380 13,983 49 % BARDA income 1,428 3,215 (1,787 ) (56 )% Operating expenses: Sales and marketing (37,291 ) (21,913 ) (15,378 ) (70 )% General and administrative (28,334 )… |
| PERCEPTIVE-ADVISORS-LLC |
PERCEPTIVE-ADVISORS-LLC |
62%
|
. For the three-months ended March 31, 2026 and 2025, the Company recognized revenue of approximately $ 8,000 and $ 64,000 , respectively, for amounts included in the beginning balance of Contract li… |
| PERCEPTIVE-CREDIT-HOLDINGS |
PERCEPTIVE-CREDIT-HOLDINGS |
62%
|
quarter of 2027, subject to the achievement of a certain revenue milestone. This facility also establishes trailing twelve-month (“TTM”) revenue covenants aligned with our current operating trajector… |
| REVOLUTION-SURGICAL-PTY-LTD |
REVOLUTION-SURGICAL-PTY-LTD |
62%
|
to the RPK and $ 358,000 in Lease revenue related to the RPD in the Consolidated Statement of Operations. Distributor Transactions For international markets, the Company exclusively partners with thi… |
| SWITZERLAND-REVOLUTION-SURGICAL-PTY-LTD |
SWITZERLAND-REVOLUTION-SURGICAL-PTY-LTD |
62%
|
pan, Joint Operations Ltd in the United Kingdom, medicalsol in Switzerland, Revolution Surgical Pty Ltd in Australia and New Zealand, and Sorbion in Austria). Revenue recognition occurs when the dist… |
| VISIOMED-GROUP-PTY-LTD-C3-OPERATIONS-PTY-LTD |
VISIOMED-GROUP-PTY-LTD-C3-OPERATIONS-PTY-LTD |
62%
|
29 )% Gross profit 42,363 28,380 13,983 49 % BARDA income 1,428 3,215 (1,787 ) (56 )% Operating expenses: Sales and marketing (37,291 ) (21,913 ) (15,378 ) (70 )% General and administrative (28,334 )… |
